{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T19:49:50Z","timestamp":1792957790205,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-006006"],"award-info":[{"award-number":["INV-006006"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.128030","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T20:25:01Z","timestamp":1764275101000},"page":"128030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Barriers to HPV vaccine introduction and revitalization in sub-Saharan francophone African countries \u2013 A qualitative descriptive study"],"prefix":"10.1016","volume":"70","author":[{"given":"Dur-E-Nayab","family":"Waheed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Bolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Burdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Biey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Karafillakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouakou S\u00e9raphin","family":"Kouassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Vorsters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10451","key":"10.1016\/j.vaccine.2025.128030_bb0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128030_bb0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2025.128030_bb0020","unstructured":"Immunization, Vaccines, and Biologicals, HPV Dashboard. WHO [Internet]. 2025 [cited 28 April 2025]. Available from: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases\/human-papillomavirus-vaccines-(HPV)\/hpv-clearing-house\/hpv-dashboard."},{"issue":"1","key":"10.1016\/j.vaccine.2025.128030_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-016496","article-title":"Implications of conflict on vaccination in the Sahel region","volume":"10","author":"Sabahelzain","year":"2025","journal-title":"BMJ glob Health."},{"key":"10.1016\/j.vaccine.2025.128030_bb0035","author":"Waheed"},{"key":"10.1016\/j.vaccine.2025.128030_bb0040","author":"Ana"},{"key":"10.1016\/j.vaccine.2025.128030_bb0045","series-title":"Guide to Introducing HPV Vaccine into National Immunization Programmes. Immunization, Vaccines and Biologicals (IVB). WHO","year":"2016"},{"key":"10.1016\/j.vaccine.2025.128030_bb0050","series-title":"Immunization, vaccines and biologicals (IVB)","author":"SCALING-UP HPV VACCINE INTRODUCTION","year":"2016"},{"key":"10.1016\/j.vaccine.2025.128030_bb0055","series-title":"HPV vaccination programs in Francophone Sub-Saharan Africa: Preparation, Introduction, Revitalization, and Sustainability","year":"2023"},{"key":"10.1016\/j.vaccine.2025.128030_bb0060","series-title":"Gavi 5.0: The alliance's 2021\u201325 strategy","year":"2019"},{"issue":"8","key":"10.1016\/j.vaccine.2025.128030_bb0065","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jval.2021.04.1273","article-title":"The CAPACITI decision-support tool for National Immunization Programs","volume":"24","author":"Botwright","year":"2021","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128030_bb0070","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/heapol\/czaa017","article-title":"Health systems constraints and facilitators of human papillomavirus immunization programmes in sub-Saharan Africa: a systematic review","volume":"35","author":"Amponsah-Dacosta","year":"2020","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.vaccine.2025.128030_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126399","article-title":"Using human papillomavirus (HPV) vaccine in controlled temperature chain (CTC): a solution looking for a problem? Or a solution to problems that are not systematically documented?","volume":"44","author":"Spasenoska","year":"2025","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.128030_bb0080","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/nutrit\/nuaf031","article-title":"Evidence on strategies for integrating nutrition interventions with health and Immunization Systems in Conflict-affected Areas of low- and lower-middle-income settings-a systematic review","volume":"83","author":"Khan","year":"2025","journal-title":"Nutr Rev"},{"key":"10.1016\/j.vaccine.2025.128030_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13031-020-0253-6","article-title":"C\u2019est vraiment compliqu\u00e9: a case study on the delivery of maternal and child health and nutrition interventions in the conflict-affected regions of Mali","volume":"14","author":"Ataullahjan","year":"2020","journal-title":"Confl Health"},{"key":"10.1016\/j.vaccine.2025.128030_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13031-020-00265-1","article-title":"Health services for women, children and adolescents in conflict affected settings: experience from north and south Kivu","volume":"14","author":"Altare","year":"2020","journal-title":"Democratic Republic of Congo Confl Health"},{"key":"10.1016\/j.vaccine.2025.128030_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13031-020-00273-1","article-title":"Health in conflict and post-conflict settings: reproductive, maternal and child health in Colombia","volume":"14","author":"Ramos Jaraba","year":"2020","journal-title":"Confl Health."},{"issue":"1","key":"10.1016\/j.vaccine.2025.128030_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188654","article-title":"How do we reach the girls and women who are the hardest to reach? Inequitable opportunities in reproductive and maternal health care services in armed conflict and forced displacement settings in Colombia","volume":"13","author":"Rivillas","year":"2018","journal-title":"PloS One"},{"issue":"10273","key":"10.1016\/j.vaccine.2025.128030_bb0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(21)00132-X","article-title":"Delivering health interventions to women, children, and adolescents in conflict settings: what have we learned from ten country case studies?","volume":"397","author":"Singh","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128030_bb0110","article-title":"School teachers\u2019 perceptions of adolescent human papillomavirus (HPV) vaccination: a systematic review","volume":"12","author":"Choi","year":"2024","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.vaccine.2025.128030_bb0115","doi-asserted-by":"crossref","first-page":"A10","DOI":"10.1016\/j.vaccine.2021.08.042","article-title":"National introduction of HPV vaccination in Senegal\u2014successes, challenges, and lessons learned","volume":"40","author":"Casey","year":"2022","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128030_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253735","article-title":"Why don\u2019t adolescent girls in a rural Uganda district initiate or complete routine 2-dose HPV vaccine series: perspectives of adolescent girls, their caregivers, healthcare workers, community health workers and teachers","volume":"16","author":"Rujumba","year":"2021","journal-title":"PloS One"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.128030_bb0125","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.vaccine.2023.10.064","article-title":"Identifying key challenges and optimizing approaches for training of health care professionals for HPV vaccination programmes","volume":"42","author":"Waheed","year":"2024","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128030_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0004007","article-title":"Improving HPV vaccine acceptance through peer-to-peer education among adolescent girls in the urban poor settings of Kisenyi, Kampala, Uganda","volume":"4","author":"Tuhebwe","year":"2024","journal-title":"PLOS Glob Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128030_bb0135","article-title":"Human papillomavirus vaccination acceleration and introduction in sub-Saharan Africa: a multi-country cohort analysis","volume":"12","author":"Adeyanju","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.128030_bb0145","series-title":"WHO adds an HPV vaccine for single-dose use [press release]","year":"2024"},{"key":"10.1016\/j.vaccine.2025.128030_bb0150","series-title":"Understanding Priorities and Needs for HPV Vaccine Advocacy - Findings from a Global Survey","year":"2023"},{"key":"10.1016\/j.vaccine.2025.128030_bb0155","doi-asserted-by":"crossref","first-page":"A38","DOI":"10.1016\/j.vaccine.2021.06.047","article-title":"Tanzania\u2019s human papillomavirus (HPV) vaccination program: community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019","volume":"40","author":"Li","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128030_bb0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41256-022-00261-3","article-title":"Examining enablers of vaccine hesitancy toward routine childhood and adolescent vaccination in Malawi","volume":"7","author":"Adeyanju","year":"2022","journal-title":"Glob Health Res Policy"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128030_bb0165","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1186\/s12889-023-15855-w","article-title":"Exploring the factors contributing to low vaccination uptake for nationally recommended routine childhood and adolescent vaccines in Kenya","volume":"23","author":"Essoh","year":"2023","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128030_bb0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/heapol\/czad106","article-title":"Getting ready for reduced donor dependency: the co-financing of family planning commodities","volume":"39","author":"Jha","year":"2024","journal-title":"Health Policy Plan"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128030_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291990","article-title":"Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries","volume":"19","author":"Guillaume","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128030_bb0180","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.vaccine.2023.06.079","article-title":"Opportunities to accelerate immunization progress in middle-income countries","volume":"42","author":"Zhu","year":"2024","journal-title":"Vaccine"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2025.128030_bb0185","article-title":"Private sector engagement for immunisation programmes: a pragmatic scoping review of 25 years of evidence on good practice in low-income and middle-income countries","volume":"8","author":"Gaurav","year":"2024","journal-title":"BMJ Glob Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:22:22Z","timestamp":1786220542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"alternative-id":["S0264410X25013283"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers to HPV vaccine introduction and revitalization in sub-Saharan francophone African countries \u2013 A qualitative descriptive study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128030"}}